Adial Pharmaceuticals, Inc. Repayments of Senior Debt
Adial Pharmaceuticals, Inc. (ADIL) reported Repayments of Senior Debt of $150.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfSeniorDebt · last filed 2020-03-20
- Adial Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2018-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2018-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2018-06-30 was $0.00.
- Adial Pharmaceuticals, Inc. repayments of senior debt for the quarter ending 2018-03-31 was $150.00K.
- Adial Pharmaceuticals, Inc. repayments of senior debt for fiscal 2018 was $150.00K.
| Period end | Repayments of Senior Debt 3 month | Repayments of Senior Debt 6 month | Repayments of Senior Debt 9 month | Repayments of Senior Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $0.00 derived: sum of 2 quarters · filed 2020-03-20 | $0.00 derived: sum of 3 quarters · filed 2020-03-20 | $150.00K 10-K · filed 2020-03-20 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $150.00K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $150.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $150.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |